Genomic Resources for Enhancing Available Therapies (GREAT1.0) Study | MicrobiomeTrials← Back to trialsNCT04306939
Genomic Resources for Enhancing Available Therapies (GREAT1.0) Study
SUSPENDEDOBSERVATIONAL
Trial Details
Start: 2014-11-01Est. Completion: 2026-12
Enrollment target: 120,000 participants Locations- University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States
Other microbiome trials you might be interested in
Pancreatitis, Chronic; Diabetes; Transplant
Patients with severe chronic pancreatitis may be candidates to have their pancreas removed and their islets transplanted…
Minneapolis, United StatesCompleted Jul 1, 2023
Chronic PainChronic Pain SyndromeChronic PancreatitisHyperalgesiaOpioid Use DisorderOpioid-Related DisordersOpioid DependenceChronic Abdominal Pain
ERCP
Pancreatic Surgery
The investigators propose to conduct a dose-escalation trial of an FDA-approved antiepileptic drug, lacosamide, added to…
Stanford, United StatesEst. completion Mar 31, 2027
IPMN, PancreaticPancreatic Cancer, ResectedPancreatic Cancer BorderlineChronic Pancreatitis
Pancreatic surgery is the only treatment in the multimodality approach to pancreatic cancer sine qua non long-term survi…
Leiden, NetherlandsEst. completion Dec 31, 2027